Parvovirus B19 by Qualitative PCR

Casandra

Casandra Test Code AR31555Version 1 (DRAFT)

Performing Lab

Lab ARUP LaboratoriesLab Test ID 0060043CPT Code 87798

Parvovirus B19 by Qualitative PCR

Also known as: PARVPCR

Clinical Use

Order Test

Use

The Parvovirus B19 by Qualitative PCR test is a nucleic acid amplification test used to detect the presence of Parvovirus B19 DNA in patient samples. It is primarily employed to assist in the diagnosis of Parvovirus B19 infections, especially in cases where it is crucial to differentiate between low-level viral persistence and active infection. This test is particularly useful for monitoring the response to treatment and predicting relapse in immunocompromised patients.

Special Instructions

This test should be used when the goal is to qualitatively detect Parvovirus B19 DNA rather than quantify viral load. It is recommended for use in plasma and serum specimens, although other specimen types such as amniotic fluid, CSF, tissue, paraffin-embedded tissue, synovial fluid, or bone marrow are also acceptable. It is important to note that this test is New York state approved.

Limitations

This test is designed to qualitatively detect the presence of Parvovirus B19; it is not suitable for determining viral load. A negative result does not rule out the presence of PCR inhibitors or the presence of Parvovirus B19 in concentrations below the detection level of the assay. It has not been cleared or approved by the FDA, but is developed and its performance characteristics determined by ARUP Laboratories under a CLIA certification for clinical use.

Test Details

New York Approved